Navigation Links
Lilly Reports Third-Quarter 2013 Results
Date:10/23/2013

.714%378.1336.612%Animal Health

530.3479.411%1,573.11,482.46%Total Revenue

$5,772.6$5,443.36%$17,304.3$16,646.04%Cymbalta
For the third quarter of 2013, Cymbalta generated $1.376 billion in revenue, an increase of 11 percent compared with the third quarter of 2012. U.S. sales of Cymbalta increased 15 percent, to $1.109 billion, driven by higher prices, partially offset by lower volume resulting from a reduction in inventory levels in both the wholesale and retail channels. The company will lose U.S. patent exclusivity for Cymbalta on December 11, 2013. Sales of Cymbalta outside the U.S. were $266.6 million, a decrease of 2 percent, driven primarily by lower prices and, to a lesser extent, the unfavorable impact of foreign exchange rates, partially offset by increased volume.

Alimta
For the third quarter of 2013, Alimta generated sales of $690.5 million, an increase of 7 percent compared with the third quarter of 2012. U.S. sales of Alimta increased 7 percent, to $310.0 million, driven by the favorable impact of buying patterns and, to a lesser extent, higher prices. Sales outside the U.S. increased 7 percent, to $380.5 million, driven by increased volume, partially offset by the unfavorable impact of foreign exchange rates.

Humalog
For the third quarter of 2013, worldwide Humalog sales increased 7 percent, to $616.0 million. Sales in the U.S. increased 6 percent to $357.8 million, driven by increased demand, partially offset by lower net effective selling prices. Sales outside the U.S. increased 8 percent to $258.2 million, driven by increased volume, partially offset by the unfavorable impact of foreign exchange rates.

Cialis
Cialis sales for the third quarter of 2013 increased 9 percent to $526.7 million. U.S. sales of Cialis were $234.0 million in the third quarter, a 14 percent increase compared with the third quarter of 2012, driven by higher prices. Sales of Cialis outside the U.S. increased 6 percent, to $29
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. FDA Grants Lillys Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer
2. Lilly Declares Fourth-Quarter 2013 Dividend
3. Lilly Reintegration Scholarship Applications Available for 2014-2015 Academic Year
4. Lilly to host investment community meeting at its Indianapolis headquarters on Thursday, October 3, 2013
5. Data Presented at 49th EASD Annual Meeting Show Treatment with Lillys Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes
6. Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint
7. Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery
8. Lilly to Present Data Across its Diabetes Portfolio at the 49th European Association for the Study of Diabetes Annual Meeting
9. Humana and Lilly Form Research Collaboration to Improve Health Care Outcomes
10. Dr. Marschall S. Runge Elected to Lilly Board of Directors
11. Lilly Reports Second-Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... GENEVA, Ill. , Jan. 15, 2014 The ... a Medical Fitness Center by the Medical Fitness Association, ... centers to achieve their full potential. The Cadence Fitness ... in the western suburbs and second in the Chicagoland ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Worldwide Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements ... announced tender offer by its indirect wholly-owned subsidiary, Sapphire ... of common stock of Solta Medical, Inc. (NASDAQ: ...
Breaking Medicine Technology:Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... MADISON, Wis.--(BUSINESS WIRE)--Jun 21, 2007 - The,PromegaExpress(TM) on-site ... to its line of on-site appliances. This,latest addition ... requirements for smaller areas when space is at ... is a necessity. The,mid-sized cabinet can also be ...
... England, 21 June 2007, Malvern Instruments has,held the ... company's,near infrared chemical imaging (NIR-CI) systems. The one-day ... hosted by AstraZeneca in,Macclesfield, UK. Malvern customers from ... technical and scientific,teams for a program that included ...
Cached Medicine Technology:Malvern initiates European user group meetings for chemical imaging 2Malvern initiates European user group meetings for chemical imaging 3
(Date:7/10/2014)... (PRWEB) July 10, 2014 Register to ... DataSite recently streamed the live webinar ‘Capitalizing on the ... from a group of several M&A experts in the ... the broader energy transaction marketplace. These experts shared their ... the deal market in this sector has been revitalized. ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 ... and believes that having family close by during ... difference in whether or not the process is ... of its website at http://www.bestdrugrehabilitation.com/success-stories/ . , ... and video testimonials from several Best Drug Rehabilitation ...
(Date:7/10/2014)... AURORA, Colo. (July 8, 2014) A new study ... some modest improvements, poor oral health remains a major ... overall. , "The oral health among Native Americans is ... the rest of the country," said Terrence Batliner, DDS, ... Health Research at the School of Public Health. "The ...
(Date:7/10/2014)... 10, 2014 (HealthDay News) -- Adults with dyslexia are ... as children or teenagers than people who don,t have ... Dyslexia, which affects up to 10 percent of ... that 35 percent of adults with this condition said ... 7 percent of those without dyslexia. "Even after ...
(Date:7/10/2014)... Thompson HealthDay Reporter THURSDAY, ... wars that break out regularly between outspoken celebrities or loudmouth ... own relationship, a new study suggests. High amounts of ... if the couple is in a long-term relationship, according to ... In turn, that friction can lead to cheating and breakups, ...
Breaking Medicine News(10 mins):Health News:Register to Download Merrill DataSite's Report: Capitalizing on the Shifting Sands of the Energy Market 2Health News:Best Drug Rehabilitation Launches New Success Stories Section of Website 2Health News:Study finds widespread oral health problems among Navajo 2Health News:Researchers See Link Between Dyslexia, Abuse 2Health News:Are You Tweeting Your Marriage Away? 2Health News:Are You Tweeting Your Marriage Away? 3
... from avian flu, bringing the total number of deaths from ... 27, a Tangerang resident, died late Friday and Jakarta resident ... two and three days of treatment in a hospital here ... flu," said an official at the Indonesian health ministry. ...
... a secret so painful that they even keep it from ... the University of Virginia, the secret exists, //and it’s big. ... high expectations for almost every area of their lives, too ... who is one of the world’s preeminent experts on women’s ...
... graduate student in the Section of Microbial Pathogenesis at ... path taken by Campylobacter// jejuni (campylobacter), as it infects ... the most common causes of diarrhea worldwide, strikes 2.4 ... few unpleasant days, but it can be life threatening ...
... prevailing trend among kids of today, who have turned ... options.// ,Researchers from university of waterloo conducted ... about eating wrong from a tender age. Parents ... which is a leading cause of increasing obesity rates, ...
... knows that a diet laden with fats and sugar, combined ... smoking is a recipe for// major problems including diabetes and ... need to realize that those same bad habits in children ... road. ,The good news: The fix is ...
... findings of a study appearing in the January 2007 issue ... discovered histamine,// the inflammatory compound released during allergic reactions that ... ,They say that histamine can be produced in large amounts ... that is the major component of pus. Pus, a fluid ...
Cached Medicine News:Health News:Women's Sex Lives Mediocre 2Health News:The Uncommon Pathway of Campylobacter Jejuni 2Health News:Cure for Most Heart Attacks Is Free, but It's Important to Start Young 2Health News:Cure for Most Heart Attacks Is Free, but It's Important to Start Young 3Health News:WBC in Lung Produces Histamine: Study 2Health News:WBC in Lung Produces Histamine: Study 3
Foldable Hydrophilic IOL with UV Absorber....
The STAAR ELASTIC LENS®, is a single piece silicone lens to be placed completely in the capsular bag....
... Engineers at Pfizer used wavefront sensing ... Optic Technology. Innovative TECNIS features a patented ... spherical aberration, which compensates for the positive ... result, TECNIS is the first and only ...
... PhacoFlexII SI30NB is foldable silicone ... it's patients. It is used ... SI30NB is indicated for primary ... of aphakia in adults (over ...
Medicine Products: